IDEXX Laboratories Inc.

NASDAQ: IDXX · Real-Time Price · USD
654.85
0.90 (0.14%)
At close: Aug 15, 2025, 1:10 PM

IDEXX Laboratories Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
288.27M 453.93M 112.55M 144.45M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
57.72M 56.19M 55.5M 18.6M
Other Long-Term Assets
364.17M 332.98M 307.01M 287.02M
Receivables
561.32M 529.53M 490.9M 425.58M
Inventory
381.88M 380.28M 367.82M 269.03M
Other Current Assets
109.81M 83.14M 88.46M 74.59M
Total Current Assets
1.4B 1.5B 1.1B 955.65M
Property-Plant & Equipment
829.25M 817.68M 768.09M 692.77M
Goodwill & Intangibles
516.78M 450.46M 459.47M 458.38M
Total Long-Term Assets
1.89B 1.76B 1.65B 1.48B
Total Assets
3.29B 3.26B 2.75B 2.44B
Account Payables
114.21M 110.64M 110.22M 116.14M
Deferred Revenue
33.8M 37.2M 37.94M 40.03M
Short-Term Debt
417.79M 325M 653.98M 148.5M
Other Current Liabilities
174.58M 174.38M 142.99M 182.93M
Total Current Liabilities
1.07B 951.55M 1.24B 763.58M
Long-Term Debt
449.79M 622.88M 694.39M 775.21M
Other Long-Term Liabilities
44.34M 65.53M 67.59M 70.94M
Total Long-Term Liabilities
630.21M 823.85M 902.23M 983.63M
Total Liabilities
1.7B 1.78B 2.14B 1.75B
Total Debt
986.95M 1.07B 1.47B 1.03B
Common Stock
10.78M 10.75M 10.72M 10.69M
Retained Earnings
5.33B 4.44B 3.6B 2.92B
Comprehensive Income
-93.64M -71.21M -77.8M -53.48M
Shareholders Equity
1.6B 1.48B 608.74M 689.99M
Total Investments
57.72M 56.19M 55.5M 18.6M